-
Prophylactic efficacy of patchoulene epoxide against ethanol-induced gastric ulcer in rats: Influence on oxidative stress, inflammation and apoptosis.
Chemico-biological interactions 20180301
-
Lansoprazole halts contrast induced nephropathy through activation of Nrf2 pathway in rats.
Chemico-biological interactions 20170525
-
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Chemical research in toxicology 20150518
-
Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study.
Chemical research in toxicology 20150316
-
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.
Toxicology letters 20150105
-
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
Chemico-biological interactions 20130905
-
Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance.
Journal of pediatric gastroenterology and nutrition 20121101
-
Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects.
Xenobiotica; the fate of foreign compounds in biological systems 20121101
-
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Journal of gastroenterology and hepatology 20121101
-
Pharmacogenomic/pharmacokinetic assessment of a four-probe cocktail for CYPs and OATPs following oral microdosing.
International journal of clinical pharmacology and therapeutics 20121001
-
Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Journal of gastroenterology and hepatology 20120901
-
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Drug metabolism and disposition: the biological fate of chemicals 20120901
-
Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects.
The Journal of clinical endocrinology and metabolism 20120901
-
Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
Helicobacter 20120801
-
Trends of outpatient prescription drug utilization in US children, 2002-2010.
Pediatrics 20120701
-
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
Bioorganic & medicinal chemistry 20120615
-
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
Journal of clinical pharmacy and therapeutics 20120601
-
Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells.
Inflammation 20120601
-
A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.
Digestive diseases and sciences 20120601
-
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Journal of medicinal chemistry 20120524
-
Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
Journal of medicinal chemistry 20120510
-
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.
European journal of clinical pharmacology 20120501
-
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Drug metabolism and disposition: the biological fate of chemicals 20120501
-
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Journal of gastroenterology 20120501
-
Absorption, distribution, metabolism and excretion of [14C]dexlansoprazole in healthy male subjects.
Clinical drug investigation 20120501
-
Conservative long-term treatment of children with eosinophilic esophagitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120501
-
Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
Journal of mass spectrometry : JMS 20120501
-
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Journal of the American College of Cardiology 20120403
-
Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole.
Molecular biology reports 20120401
-
Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Cancer chemotherapy and pharmacology 20120401
-
Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group.
Chirality 20120401
-
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Journal of digestive diseases 20120401
-
Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.
Journal of gastroenterology and hepatology 20120401
-
Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test.
Journal of clinical pharmacology 20120301
-
Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.
European journal of clinical pharmacology 20120301
-
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Acta dermato-venereologica 20120301
-
The safety of fetal exposure to proton-pump inhibitors during pregnancy.
Digestive diseases and sciences 20120301
-
Acid suppression for reflux disease: 'off-the-peg' or a tailored approach?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120301
-
Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120301
-
Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus.
Journal of the Formosan Medical Association = Taiwan yi zhi 20120301
-
Development and validation of a highly sensitive LC-MS/MS method for quantitation of dexlansoprazole in human plasma: application to a human pharmacokinetic study.
Biomedical chromatography : BMC 20120201
-
Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
Digestive diseases and sciences 20120201
-
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.
JAMA 20120125
-
Children, asthma, and proton pump inhibitors: costs and perils of therapeutic creep.
JAMA 20120125
-
Tranexamic acid for upper gastrointestinal bleeding.
The Cochrane database of systematic reviews 20120118
-
Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.
Pharmaceutical development and technology 20120101
-
Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea.
British journal of clinical pharmacology 20120101
-
Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD.
Journal of pediatric gastroenterology and nutrition 20120101
-
Freeze dried chitosan/ poly-(glutamic acid) microparticles for intestinal delivery of lansoprazole.
Current drug delivery 20120101
-
Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment.
European journal of dermatology : EJD 20120101
-
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Scandinavian journal of gastroenterology 20120101
-
Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin.
Digestion 20120101
-
Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
Archives of Iranian medicine 20120101
-
Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.
Digestion 20120101
-
Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study.
Medical science monitor : international medical journal of experimental and clinical research 20120101
-
Spontaneous splenic rupture and Anisakis appendicitis presenting as abdominal pain: a case report.
Journal of medical case reports 20120101
-
[Effect of pharmaceutical care in the diagnosis of Helicobacter pylori infection using 13C-urea breath test].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101
-
[Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
Terapevticheskii arkhiv 20120101
-
In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
Digestion 20120101
-
Antiprotozoal activity of proton-pump inhibitors.
Bioorganic & medicinal chemistry letters 20111215
-
Time to stop blaming gastroesophageal reflux.
Clinical pediatrics 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Gut 20111101
-
Helicobacter pylori infection-related pancytopenia in a young boy.
Pediatric hematology and oncology 20111101
-
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
Drug metabolism and disposition: the biological fate of chemicals 20111101
-
Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
Journal of gastroenterology 20111101
-
Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data.
The American journal of gastroenterology 20111101
-
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.
The American journal of gastroenterology 20111101
-
Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111101
-
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Journal of clinical pharmacology 20111001
-
Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux?
Auris, nasus, larynx 20111001
-
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
Gastroenterology 20111001
-
Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects.
Clinical drug investigation 20111001
-
Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.
The Journal of pharmacy and pharmacology 20111001
-
Perforated dried blood spots: a novel format for accurate microsampling.
Bioanalysis 20111001
-
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Lancet (London, England) 20110806
-
Mass eradication of Helicobacter pylori: feasible and advisable?
Lancet (London, England) 20110806
-
Dexlansoprazole MR: a review.
Annals of medicine 20110801
-
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Journal of gastroenterology 20110801
-
Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
Alimentary pharmacology & therapeutics 20110801
-
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
Expert review of gastroenterology & hepatology 20110801
-
Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Clinical therapeutics 20110801
-
Gastroprotective activity of epitaondiol and sargaol.
Natural product communications 20110801
-
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
Journal of medicinal chemistry 20110714
-
Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Journal of clinical pharmacology 20110701
-
Does long-term aspirin use have any effect on Helicobacter pylori eradication?
The American journal of the medical sciences 20110701
-
Zollinger-Ellison syndrome: presentation, response to therapy, and outcome.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110601
-
Gastroprotective effect and cytotoxicity of carnosic acid derivatives.
Planta medica 20110601
-
Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.
Drug metabolism and pharmacokinetics 20110601
-
A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
The Journal of pharmacology and experimental therapeutics 20110601
-
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Journal of gastroenterology 20110601
-
Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects.
Xenobiotica; the fate of foreign compounds in biological systems 20110601
-
A new modified concomitant therapy for Helicobacter pylori eradication in Turkey.
Helicobacter 20110601
-
Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice?
Minerva medica 20110601
-
Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions.
Journal of chromatography. A 20110520
-
Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110501
-
Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test.
Journal of gastroenterology and hepatology 20110501
-
Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes.
Glia 20110501
-
A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands.
Biochemical pharmacology 20110501
-
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
Pediatrics 20110501
-
Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?
Scandinavian journal of gastroenterology 20110401
-
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori.
Journal of medicinal food 20110401
-
Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.
Journal of clinical pharmacy and therapeutics 20110401
-
Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection.
The Indian journal of medical research 20110401
-
[Study on pharmacokinetics of lansoprozole in concentration of blood plasma healthy volunteers intravenous infusion by improved HPLC].
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20110401
-
Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats.
Journal of ethnopharmacology 20110324
-
Gastroprotective effect and cytotoxicity of labdeneamides with amino acids.
Planta medica 20110301
-
Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Scandinavian journal of gastroenterology 20110301
-
Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors.
Scandinavian journal of gastroenterology 20110301
-
CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualization in H. pylori eradication.
European journal of clinical pharmacology 20110301
-
Attenuation of stress-induced gastric lesions by lansoprazole, PD-136450 and ranitidine in rats.
Molecular and cellular biochemistry 20110301
-
The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
The American journal of gastroenterology 20110301
-
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301
-
A new strategy of transforming pharmaceutical crystal forms.
Journal of the American Chemical Society 20110209
-
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
Journal of gastroenterology 20110201
-
Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication.
Journal of gastroenterology 20110201
-
The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 20110201
-
Comparison of two different treatment protocols in Helicobacter pylori eradication.
Southern medical journal 20110201
-
Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.
Helicobacter 20110201
-
Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20110201
-
Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping.
Nagoya journal of medical science 20110201
-
Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H(+), K(+)-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism.
Evidence-based complementary and alternative medicine : eCAM 20110101
-
The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
Archives of disease in childhood 20110101
-
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Pharmacological research 20110101
-
Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients.
Biological & pharmaceutical bulletin 20110101
-
Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
Digestion 20110101
-
Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.
Internal medicine (Tokyo, Japan) 20110101
-
[Prodrug technology in the development of medicinal agents].
Duodecim; laaketieteellinen aikakauskirja 20110101
-
Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor.
Arzneimittel-Forschung 20110101
-
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
PloS one 20110101
-
Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
Asian Pacific journal of cancer prevention : APJCP 20110101
-
Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention.
Vascular health and risk management 20110101
-
Use of a new ziprasidone-selective electrode in mixed solvents and its application in the analysis of pharmaceuticals and biological fluids.
Sensors (Basel, Switzerland) 20110101
-
Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.
Journal of translational medicine 20110101
-
Lansoprazole induces collagenous colitis in the colon of Mongolian gerbils.
Asian Pacific journal of cancer prevention : APJCP 20110101
-
Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole.
Digestive diseases and sciences 20101201
-
Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse.
Digestive diseases and sciences 20101201
-
Proton pump inhibitor therapy improves symptoms in postnasal drainage.
Gastroenterology 20101201
-
Novel approaches to inhibition of gastric acid secretion.
Current gastroenterology reports 20101201
-
Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.
World journal of gastroenterology 20101114
-
Allergic angina can be determined by the early use of cardiac magnetic resonance imaging.
The American journal of emergency medicine 20101101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis.
The Laryngoscope 20101101
-
Safety profile of six months lansoprozole treatment in children.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20101101
-
Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes.
Diabetologia 20101001
-
Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.
Neurocritical care 20101001
-
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
The Journal of pharmacology and experimental therapeutics 20101001
-
Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy.
Alimentary pharmacology & therapeutics 20101001
-
Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa.
Helicobacter 20101001
-
Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20101001
-
Liquid chromatography/tandem mass spectrometry sensitivity enhancement via online sample dilution and trapping: applications in microdosing and dried blood spot (DBS) bioanalysis.
Rapid communications in mass spectrometry : RCM 20100915
-
Age-dependent eradication of Helicobacter pylori in Japanese patients.
World journal of gastroenterology 20100907
-
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Journal of gastrointestinal cancer 20100901
-
Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.
Xenobiotica; the fate of foreign compounds in biological systems 20100901
-
Influences of sodium carbonate on physicochemical properties of lansoprazole in designed multiple coating pellets.
AAPS PharmSciTech 20100901
-
[Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100901
-
Dexlansoprazole modified release: in erosive oesophagitis and non-erosive reflux disease.
Drugs 20100820
-
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100801
-
Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer.
Journal of gastroenterology 20100801
-
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Gastroenterology 20100801
-
Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs.
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 20100801
-
The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects.
Pharmaceutical biology 20100801
-
Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
Clinical therapeutics 20100801
-
Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration.
Chirality 20100701
-
How to manage Helicobacter pylori after sequential therapy failure?
Journal of clinical gastroenterology 20100701
-
Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy.
Alimentary pharmacology & therapeutics 20100701
-
A majority of tube-fed patients are on medications that require special precautions.
Age and ageing 20100701
-
Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole.
Alimentary pharmacology & therapeutics 20100701
-
Clinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo.
Alimentary pharmacology & therapeutics 20100701
-
Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib.
Pharmacotherapy 20100701
-
Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601
-
Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole.
Digestive diseases and sciences 20100501
-
Ten-day sequential therapy of Helicobacter pylori infection in Thailand.
The American journal of gastroenterology 20100501
-
Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist.
Biochemical pharmacology 20100501
-
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.
European journal of gastroenterology & hepatology 20100501
-
Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness.
Scandinavian journal of gastroenterology 20100501
-
The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor.
Alimentary pharmacology & therapeutics 20100501
-
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20100501
-
Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.
The Annals of pharmacotherapy 20100501
-
The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
Methods and findings in experimental and clinical pharmacology 20100501
-
Gastroprotective effect of carnosic acid gamma-lactone derivatives.
Journal of natural products 20100423
-
Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.
Bone 20100401
-
Suppression of phosphorylation of extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase in polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100401
-
Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Alimentary pharmacology & therapeutics 20100401
-
Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study.
Journal of Korean medical science 20100401
-
Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
Journal of clinical gastroenterology 20100301
-
Inappropriate use of proton pump inhibitors.
Irish journal of medical science 20100301
-
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.
Journal of thrombosis and haemostasis : JTH 20100301
-
A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children.
Journal of separation science 20100301
-
Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301
-
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301
-
Hypothesis testing for the validation of the kinetic spectrophotometric methods for the determination of lansoprazole in bulk and drug formulations via Fe(III) and Zn(II) chelates.
Drug testing and analysis 20100301
-
Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Drug development and industrial pharmacy 20100201
-
[Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients].
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100201
-
Dexlansoprazole for the treatment of esophagitis and GERD.
Drugs of today (Barcelona, Spain : 1998) 20100201
-
Generics offer pharmacy plans specific benefits.
Managed care (Langhorne, Pa.) 20100201
-
Two-dimensional chromatography method applied to the enantiomeric determination of lansoprazole in human plasma by direct sample injection.
Chirality 20100101
-
Costs and risks in the management of patients with gastric acid hypersecretion.
Journal of clinical gastroenterology 20100101
-
Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
Drug development and industrial pharmacy 20100101
-
Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis.
Endoscopy 20100101
-
Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life?
Digestion 20100101
-
Patient self-treatment using lansoprazole for frequent nighttime heartburn. Commentary.
Postgraduate medicine 20100101
-
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 20100101
-
[Case of suspicious lansoprazole-associated collagenous colitis in ANCA-associated nephritis].
Nihon Jinzo Gakkai shi 20100101
-
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101
-
[How to choose correct proton pump inhibitors to patients with GERD?].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101
-
Multiple congenital red-brown macules, thrombocytopenia, and gastrointestinal bleeding. Diagnosis: Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT).
Pediatric dermatology 20100101
-
Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
Hepato-gastroenterology 20100101
-
Long term changes in platelet counts after H. pylori eradication in non-ITP patients.
Platelets 20100101
-
Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
European journal of dermatology : EJD 20100101
-
[Lanzoptol efficacy at gastroesophageal reflux disease: results of multicenter study leader].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101
-
Gastric emptying and electrogastrography in reflux esophagitis: results in patients showing endoscopically erosive esophagitis under proton pump inhibitor therapy.
Hepato-gastroenterology 20100101
-
Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.
Mediators of inflammation 20100101
-
Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori?
Hepato-gastroenterology 20100101
-
Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants.
Journal of clinical pharmacology 20091201
-
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Presse medicale (Paris, France : 1983) 20091201
-
Gastroprotective effect and cytotoxicity of abietane diterpenes from the Chilean Lamiaceae Sphacele chamaedryoides (Balbis) Briq.
The Journal of pharmacy and pharmacology 20091201
-
Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20091201
-
Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.
Alimentary pharmacology & therapeutics 20091115
-
Optimization of melt pelletization in a high shear mixer.
International journal of pharmaceutics 20091103
-
Comparing the acid-suppressive effects of three brands of generic lansoprazole with the original: pharmacokinetic bioequivalence tests do not necessarily guarantee pharmacodynamic equivalence.
Digestive diseases and sciences 20091101
-
Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief.
Alimentary pharmacology & therapeutics 20091101
-
Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura.
[Rinsho ketsueki] The Japanese journal of clinical hematology 20091101
-
Long-term treatment with proton pump inhibitor is associated with undesired weight gain.
World journal of gastroenterology 20091014
-
[Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets].
Gastroenterologia y hepatologia 20091001
-
Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1.
The Journal of pharmacology and experimental therapeutics 20091001
-
Dexlansoprazole MR.
Expert opinion on pharmacotherapy 20091001
-
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Nature chemical biology 20091001
-
Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen.
Clinical trials (London, England) 20091001
-
Cough syncope induced by gastroesophageal reflux disease.
Journal of cardiology 20091001
-
Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction.
World journal of gastroenterology 20090921
-
Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.
Alimentary pharmacology & therapeutics 20090915
-
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
World journal of gastroenterology 20090914
-
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects.
Alimentary pharmacology & therapeutics 20090901
-
Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL.
Journal of medical economics 20090901
-
Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(-)-lansoprazole enantiomers and related impurities.
Journal of pharmaceutical and biomedical analysis 20090815
-
Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
European journal of clinical pharmacology 20090801
-
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study.
Annals of hematology 20090801
-
High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090801
-
Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.
Digestive diseases and sciences 20090801
-
[13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole.
Alimentary pharmacology & therapeutics 20090801
-
A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients.
Journal of the American Geriatrics Society 20090801
-
Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
Journal of cardiovascular pharmacology 20090801
-
Potential of lansoprazole as a novel probe for cytochrome P450 3A activity by measuring lansoprazole sulfone in human liver microsomes.
Biological & pharmaceutical bulletin 20090801
-
Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis.
Journal of the American Geriatrics Society 20090801
-
Optimisation and validation of a new CE method for the determination of lansoprazole enantiomers in pharmaceuticals.
Electrophoresis 20090801
-
Transmucosal gastric leak induced by proton pump inhibitors.
Digestive diseases and sciences 20090701
-
CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole.
European journal of clinical pharmacology 20090701
-
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
Biomedical chromatography : BMC 20090701
-
Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
Alimentary pharmacology & therapeutics 20090701
-
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
The American journal of the medical sciences 20090701
-
Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.
Journal of gastroenterology and hepatology 20090701
-
Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.
Postgraduate medicine 20090701
-
The clinical safety of long-term lansoprazole for the maintenance of healed erosive oesophagitis.
Alimentary pharmacology & therapeutics 20090615
-
Interaction between clopidogrel and proton pump inhibitors.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609
-
Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects.
European journal of clinical pharmacology 20090601
-
Lansoprazole, ranitidine, and metoclopramide: comparison of practice patterns at 4 level III NICUs within one healthcare system.
Advances in neonatal care : official journal of the National Association of Neonatal Nurses 20090601
-
Differential pulse polarographic investigation of lansoprazole and rabeprazole using dropping mercury electrode.
Die Pharmazie 20090601
-
Hypersensitivity to proton pump inhibitors: lansoprazole-induced Kounis syndrome.
International journal of cardiology 20090529
-
Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis.
World journal of gastroenterology 20090507
-
Lansoprazole for long-term maintenance therapy of erosive esophagitis: double-blind comparison with ranitidine.
Digestive diseases and sciences 20090501
-
Unique endoscopy findings in collagenous colitis.
Gastrointestinal endoscopy 20090501
-
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.
Experimental neurology 20090501
-
Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.
Alimentary pharmacology & therapeutics 20090501
-
The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor.
The American journal of gastroenterology 20090501
-
[Eosinophilic esophagitis: report of three cases].
Revista medica de Chile 20090501
-
Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibility.
Alimentary pharmacology & therapeutics 20090415
-
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
Journal of clinical gastroenterology 20090401
-
Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
The Journal of pediatrics 20090401
-
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.
Drug metabolism and disposition: the biological fate of chemicals 20090401
-
Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation--results from two randomized controlled studies.
Alimentary pharmacology & therapeutics 20090401
-
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis.
Alimentary pharmacology & therapeutics 20090401
-
Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.
Journal of clinical pharmacology 20090401
-
Stop the PPI express: they don't keep babies quiet!
The Journal of pediatrics 20090401
-
Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
The Medical letter on drugs and therapeutics 20090323
-
Association of laryngopharyngeal manifestations and gastroesophageal reflux.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20090301
-
Controlled, household-randomized, open-label trial of the effect of treatment of Helicobacter pylori infection on iron deficiency among children in rural Alaska: results at 40 months.
The Journal of infectious diseases 20090301
-
Lansoprazole-induced acute interstitial nephritis.
Southern medical journal 20090301
-
Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials.
Current medical research and opinion 20090301
-
Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
World journal of gastroenterology 20090227
-
Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse.
Theriogenology 20090201
-
Acido-basic properties of proton pump inhibitors in aqueous solutions.
Drug development and industrial pharmacy 20090101
-
Effect of oral lansoprazole on intragastric pH after endoscopic treatment for bleeding peptic ulcer.
Scandinavian journal of gastroenterology 20090101
-
Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.
Clinical drug investigation 20090101
-
Effect of oral lansoprazole on intragastric pH after endoscopic treatment for bleeding peptic ulcer.
Scandinavian journal of gastroenterology 20090101
-
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.
BMC gastroenterology 20090101
-
Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase.
Acta biochimica Polonica 20090101
-
Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.
Hepato-gastroenterology 20090101
-
Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
Hepato-gastroenterology 20090101
-
Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis?
Clinical and experimental rheumatology 20090101
-
Acute kidney injury in patients with inactive cytochrome P450 polymorphisms.
Renal failure 20090101
-
Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis.
Endoscopy 20090101
-
Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication.
Arquivos de gastroenterologia 20090101
-
[Lanzoptol efficiency for heartburn alleviation in patients with NERD].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
-
[Morphological changes in the intestinal mucosa of the large intestine under the blockage of H+,K+ -ATPase and CCK-2 gastrin receptors].
Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20090101
-
Severe hypomagnesaemia due to lansoprazole.
BMJ case reports 20090101
-
Determination of lansoprazole in human plasma by rapid resolution liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study on Chinese volunteers.
Journal of pharmaceutical and biomedical analysis 20081215
-
[Nocturnal shortness of breath: in asthma look for reflux -- is it worthwhile?].
MMW Fortschritte der Medizin 20081211
-
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Alimentary pharmacology & therapeutics 20081201
-
Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC-MS/MS: application to a pharmacokinetic study in healthy volunteers.
Journal of pharmaceutical and biomedical analysis 20081201
-
Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
Helicobacter 20081201
-
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Helicobacter 20081201
-
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Helicobacter 20081201
-
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Helicobacter 20081201
-
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
Presse medicale (Paris, France : 1983) 20081001
-
Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Gastrointestinal endoscopy 20081001
-
Dexlansoprazole, a modified release formulation of an enantiomer of lansoprazole, for the treatment of reflux esophagitis.
Current opinion in investigational drugs (London, England : 2000) 20081001
-
Lansoprazole in globus pharyngeus: double-blind, randomized, placebo-controlled trial.
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20081001
-
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Lancet (London, England) 20080802
-
Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin.
The Thoracic and cardiovascular surgeon 20080801
-
Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?
Journal of cardiology 20080801
-
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801
-
Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.
Alimentary pharmacology & therapeutics 20080801
-
Relationship between herd size and the prevalence of PRRS in pig herds in China.
The Veterinary record 20080719
-
Watermelon stomach.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080715
-
Endoscopic patterns and histopathological features after eradication therapy in Helicobacter pylori-associated nodular gastritis.
Digestive diseases and sciences 20080701
-
The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
The Journal of pharmacology and experimental therapeutics 20080701
-
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Alimentary pharmacology & therapeutics 20080701
-
Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.
Biochemical pharmacology 20080701
-
Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701
-
Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat.
Pharmacological research 20080701
-
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.
World journal of gastroenterology 20080628
-
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Journal of medicinal chemistry 20080612
-
Genotyping of Cryptosporidium isolates from human clinical cases in Poland.
Parasitology research 20080601
-
Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.
Alimentary pharmacology & therapeutics 20080601
-
Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis.
Gastrointestinal endoscopy 20080601
-
Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.
The Journal of biological chemistry 20080523
-
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
European journal of clinical pharmacology 20080501
-
Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.
British journal of clinical pharmacology 20080501
-
Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers.
Journal of separation science 20080501
-
Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.
Scandinavian journal of gastroenterology 20080501
-
Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Journal of pediatric gastroenterology and nutrition 20080501
-
The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids.
Journal of biochemical and biophysical methods 20080424
-
Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
World journal of gastroenterology 20080421
-
Extraintestinal heterotopic gastric tissue simulating acute appendicitis.
World journal of gastroenterology 20080414
-
Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.
World journal of gastroenterology 20080407
-
Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
American journal of hematology 20080401
-
Is lansoprazole effective for the initial management of young patients with dyspepsia?
Nature clinical practice. Gastroenterology & hepatology 20080401
-
Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
Journal of clinical pharmacology 20080401
-
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080401
-
[Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401
-
Persistent atrial fibrillation associated with gastroesophageal reflux accompanied by hiatal hernia.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080401
-
Acute interstitial nephritis related to lansoprazole administration.
JPMA. The Journal of the Pakistan Medical Association 20080401
-
Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.
Alimentary pharmacology & therapeutics 20080315
-
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Laboratory investigation; a journal of technical methods and pathology 20080301
-
The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
Journal of clinical gastroenterology 20080301
-
Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
Pharmacotherapy 20080301
-
Evidence for the ''paradox'' association between hypertensive lower esophageal sphincter and gastroesophageal reflux disease.
Minerva gastroenterologica e dietologica 20080301
-
Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux.
Journal of pediatric gastroenterology and nutrition 20080301
-
Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition.
Regulatory peptides 20080207
-
Long-term proton pump inhibitor use in children: a retrospective review of safety.
Digestive diseases and sciences 20080201
-
Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
Journal of gastroenterology and hepatology 20080201
-
Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care.
Current medical research and opinion 20080201
-
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Journal of clinical gastroenterology 20080201
-
Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation.
Therapeutic drug monitoring 20080201
-
Gastroprotective activity of ferruginol in mice and rats: effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls.
The Journal of pharmacy and pharmacology 20080201
-
[Pharmacological and clinical profile of lansoprazole (Takepron IV injection 30 mg)].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080201
-
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Journal of gastroenterology and hepatology 20080101
-
Effects of dexmedetomidine infusion in patients undergoing functional endoscopic sinus surgery under local anaesthesia.
European journal of anaesthesiology 20080101
-
Genotype 3 hepatitis E has been widespread in pig farms of Shanghai suburbs.
Veterinary microbiology 20080101
-
Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
Alimentary pharmacology & therapeutics 20080101
-
Superior mesenteric artery syndrome: an uncommon cause of feeding intolerance in infancy.
Journal of pediatric gastroenterology and nutrition 20080101
-
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Acta dermato-venereologica 20080101
-
A novel 'peak parking' strategy for ultra-performance liquid chromatography/tandem mass spectrometric detection for enhanced performance of bioanalytical assays.
Rapid communications in mass spectrometry : RCM 20080101
-
Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.
Korean journal of radiology 20080101
-
Stereoselective disposition of proton pump inhibitors.
Clinical drug investigation 20080101
-
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5.
Drug metabolism and pharmacokinetics 20080101
-
Persistent oxidative stress in the corpus mucosa is evoked by long-term treatment of H. pylori-infected patients with proton pump inhibitors.
Hepato-gastroenterology 20080101
-
Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole.
BMC gastroenterology 20080101
-
Activation and stabilization of drugs by supramolecular pKa shifts: drug-delivery applications tailored for cucurbiturils.
Angewandte Chemie (International ed. in English) 20080101
-
Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
Paediatric drugs 20080101
-
Age-dependent pharmacokinetics of lansoprazole in neonates and infants.
Paediatric drugs 20080101
-
Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
Reviews in gastroenterological disorders 20080101
-
Gastroprotective and anti-oxidative properties of ascorbic acid on indomethacin-induced gastric injuries in rats.
Biological trace element research 20080101
-
Triple therapies plus different probiotics for Helicobacter pylori eradication.
European review for medical and pharmacological sciences 20080101
-
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen.
Digestion 20080101
-
Henoch-Schönlein purpura associated with Helicobacter pylori infection in a child.
Pediatric dermatology 20080101
-
The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study.
Journal of gastroenterology 20080101
-
[Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101
-
Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsule dosage form.
Indian journal of pharmaceutical sciences 20080101
-
[Therapeutic innovations in gastroesophageal reflux].
Presse medicale (Paris, France : 1983) 20071201
-
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071201
-
Population pharmacokinetics and proton pump inhibitory effects of intravenous lansoprazole in healthy Japanese males.
Biological & pharmaceutical bulletin 20071201
-
Dyspepsia in childhood and adolescence: insights and treatment considerations.
Current gastroenterology reports 20071201
-
Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy.
Clinical endocrinology 20071101
-
Pseudochromhidrosis: blue discolouration of the head and neck.
The Australasian journal of dermatology 20071101
-
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Journal of digestive diseases 20071101
-
Gastroprotective and antioxidant effects of amiodarone on indomethacin-induced gastric ulcers in rats.
Archives of pharmacal research 20071101
-
[Drug treatment and surgical indications in gastroesophageal reflux].
Revista de gastroenterologia de Mexico 20071101
-
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned.
Digestive diseases and sciences 20071001
-
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071001
-
Gastroprotective effect of mangiferin, a xanthonoid from Mangifera indica, against gastric injury induced by ethanol and indomethacin in rodents.
Planta medica 20071001
-
Proton pump inhibitor utilization patterns in infants.
Journal of pediatric gastroenterology and nutrition 20071001
-
Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Alimentary pharmacology & therapeutics 20070915
-
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
World journal of gastroenterology 20070907
-
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.
Gut 20070901
-
Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles.
Chirality 20070901
-
Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
Alimentary pharmacology & therapeutics 20070901
-
Epstein-Barr virus gastritis: an underrecognized form of severe gastritis simulating gastric lymphoma.
The American journal of surgical pathology 20070901
-
Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats.
Journal of pharmacological sciences 20070901
-
CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.
Pharmacogenomics 20070901
-
Immune and Inflammatory Responses in GERD and Lansoprazole.
Journal of clinical biochemistry and nutrition 20070901
-
[Drug-induced microscopic colitis].
Praxis 20070829
-
Stimulation programs for pediatric drug research--do children really benefit?
European journal of pediatrics 20070801
-
Zollinger Ellison syndrome, treated with lansoprazole, during pregnancy.
Archives of gynecology and obstetrics 20070801
-
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Helicobacter 20070801
-
Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Helicobacter 20070801
-
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Helicobacter 20070801
-
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Journal of gastroenterology 20070801
-
Effect of famotidine and lansoprazole on serum phosphorus levels in hemodialysis patients on calcium carbonate therapy.
Clinical nephrology 20070801
-
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.
World journal of gastroenterology 20070728
-
Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.
Digestive diseases and sciences 20070701
-
Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.
The American journal of gastroenterology 20070701
-
Antiulcerogenic effect and acute toxicity of a hydroethanolic extract from the cashew (Anacardium occidentale L.) leaves.
Journal of ethnopharmacology 20070613
-
Effects of uptake and efflux transporter inhibition on erythromycin breath test results.
Clinical pharmacology and therapeutics 20070601
-
Use of ceric ammonium sulphate and two dyes, methyl orange and indigo carmine, in the determination of lansoprazole in pharmaceuticals.
Acta pharmaceutica (Zagreb, Croatia) 20070601
-
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Hepato-gastroenterology 20070601
-
Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?
Journal of gastroenterology 20070601
-
Long-term management of gastroesophageal reflux disease with pantoprazole.
Therapeutics and clinical risk management 20070601
-
Gastroprotective effect and cytotoxicity of terpenes from the Paraguayan crude drug 'yagua rova' (Jatropha isabelli).
Journal of ethnopharmacology 20070522
-
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.
Biopharmaceutics & drug disposition 20070501
-
[Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
Nihon rinsho. Japanese journal of clinical medicine 20070501
-
[Three cases of muscle tension dysphonia improved using proton pump inhibitors].
Nihon Jibiinkoka Gakkai kaiho 20070501
-
[Helicobacter pylori infection and probiotics].
Nihon saikingaku zasshi. Japanese journal of bacteriology 20070501
-
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004.
Journal of toxicology and environmental health. Part A 20070415
-
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.
Clinical pharmacology and therapeutics 20070401
-
Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070401
-
Proton pump inhibitors: effective first-line treatment for management of dyspepsia.
Digestive diseases and sciences 20070401
-
[A case of gastroesophageal reflux disease with marked eosinophilia].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20070401
-
Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature.
Scandinavian journal of gastroenterology 20070401
-
[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].
Orvosi hetilap 20070325
-
Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center.
Alimentary pharmacology & therapeutics 20070315
-
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.
World journal of gastroenterology 20070314
-
Inhibition of gastric H+, K+-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale.
Molecular nutrition & food research 20070301
-
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration.
The Journal of pediatrics 20070301
-
Constituents and antiulcer effect of Alchornea glandulosa: activation of cell proliferation in gastric mucosa during the healing process.
Biological & pharmaceutical bulletin 20070301
-
Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070301
-
Key points in the management of gastroesophageal reflux disease.
Current gastroenterology reports 20070301
-
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
Hepato-gastroenterology 20070301
-
Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Alimentary pharmacology & therapeutics 20070201
-
Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis.
Journal of gastroenterology and hepatology 20070201
-
Acid control with esomeprazole and lansoprazole: a comparative dose-response study.
Scandinavian journal of gastroenterology 20070201
-
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Platelets 20070201
-
Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
Alimentary pharmacology & therapeutics 20070115
-
Influence of smoking and CYP2C19 genotypes on H. pylori eradication success.
Epidemiology and infection 20070101
-
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatment.
Medical hypotheses 20070101
-
Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota.
International journal of antimicrobial agents 20070101
-
Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
Naunyn-Schmiedeberg's archives of pharmacology 20070101
-
Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
Journal of pediatric gastroenterology and nutrition 20070101
-
Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population.
Cough (London, England) 20070101
-
Lansoprazole increases serum IgG and IgM in H. pylori-infected patients.
International journal of immunopathology and pharmacology 20070101
-
Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients.
Clinical drug investigation 20070101
-
Eradication of Helicobacter pylori in hemodialysis patients.
Renal failure 20070101
-
Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease.
Respiration; international review of thoracic diseases 20070101
-
[Otorhinolaringologyc approach of the chronic cough. Clinical case].
Anales otorrinolaringologicos ibero-americanos 20070101
-
A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients.
Digestion 20070101
-
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Klinicheskaia meditsina 20070101
-
Healing of severe reflux esophagitis with PPI does not improve esophageal dysmotility.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20070101
-
Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101
-
Role of oxidative stress in lansoprazole-mediated gastric and hepatic protection in Wistar rats.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101
-
Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease : ACEPTO study.
Clinical drug investigation 20070101
-
Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice.
Microbiology and immunology 20070101
-
[Influence of omeprasole and lansoprasole on Na+, K+ -ATPase and Mg2+ -ATPase activity of the plasmatic membrane of myometrium smooth muscle cells].
Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20070101
-
Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20061201
-
Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens.
Pharmacological research 20061201
-
Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Japanese journal of infectious diseases 20061201
-
Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus.
International journal of clinical pharmacology and therapeutics 20061201
-
An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube.
Alimentary pharmacology & therapeutics 20061201
-
Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori.
Journal of the South Carolina Medical Association (1975) 20061201
-
Common antacids could help keep gingivitis at bay.
British dental journal 20061125
-
[Safety of proton pump inhibitors].
Medicina clinica 20061125
-
A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study.
Alimentary pharmacology & therapeutics 20061115
-
Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.
Archives of oral biology 20061101
-
Suppression of proinflammatory cytokine production in macrophages by lansoprazole.
Pediatric surgery international 20061101
-
Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101
-
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20061101
-
Treatment of gastroesophageal reflux disease.
Jornal de pediatria 20061101
-
An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile.
International journal of pharmaceutics 20061012
-
Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats.
Life sciences 20061004
-
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Helicobacter 20061001
-
Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
Journal of clinical pharmacology 20061001
-
The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma.
Expert opinion on pharmacotherapy 20061001
-
Helicobacter pylori infection with a duodenal ulcer in a 6-year-old boy.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20061001
-
[Dosaging of proton pumps inhibitors].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060921
-
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
Alimentary pharmacology & therapeutics 20060901
-
The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study.
Methods and findings in experimental and clinical pharmacology 20060901
-
Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships.
Life sciences 20060829
-
Contrast-enhanced ultrasonographic assessment of the response of Ménétrier disease to Helicobacter pylori eradication therapy.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20060801
-
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Pharmacy world & science : PWS 20060801
-
Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells.
Biochemical and biophysical research communications 20060707
-
Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701
-
A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.
The Tohoku journal of experimental medicine 20060701
-
The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.
The American journal of gastroenterology 20060701
-
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
Journal of gastroenterology 20060701
-
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.
International journal of clinical pharmacology and therapeutics 20060701
-
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
World journal of gastroenterology 20060628
-
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Helicobacter 20060601
-
Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.
Alimentary pharmacology & therapeutics 20060601
-
Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
Chemical & pharmaceutical bulletin 20060601
-
Enantioselective disposition of lansoprazole and rabeprazole in human plasma.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601
-
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
European journal of clinical pharmacology 20060601
-
Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve.
Therapeutic drug monitoring 20060601
-
Pill esophagitis caused by telithromycin: a case report.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060601
-
[Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux].
Arerugi = [Allergy] 20060601
-
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 20060515
-
Degradation of lansoprazole and omeprazole in the aquatic environment.
Chemosphere 20060501
-
Ion flow regulates left-right asymmetry in sea urchin development.
Development genes and evolution 20060501
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
Alimentary pharmacology & therapeutics 20060501
-
Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.
Digestive diseases and sciences 20060501
-
Hydroxyl radical scavenging reactivity of proton pump inhibitors.
Biochemical pharmacology 20060428
-
Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
Alimentary pharmacology & therapeutics 20060415
-
Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060401
-
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.
Alimentary pharmacology & therapeutics 20060401
-
Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
Alimentary pharmacology & therapeutics 20060401
-
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
Clinical pharmacology and therapeutics 20060401
-
Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet.
Chemical & pharmaceutical bulletin 20060401
-
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
World journal of gastroenterology 20060321
-
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Alimentary pharmacology & therapeutics 20060315
-
Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307
-
Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
Respiratory medicine 20060301
-
Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.
Rheumatology (Oxford, England) 20060301
-
Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.
British journal of clinical pharmacology 20060301
-
Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.
Pharmacotherapy 20060301
-
Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors.
The Journal of allergy and clinical immunology 20060301
-
Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060301
-
Microscopic colitis associated with exposure to lansoprazole.
The Medical journal of Australia 20060220
-
[Gastric protection and treatment with low-dose aspirin].
Medicina clinica 20060218
-
Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
European journal of pharmacology 20060215
-
Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201
-
Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.
European journal of clinical pharmacology 20060201
-
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 20060201
-
Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
World journal of gastroenterology 20060107
-
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20060101
-
Fatal toxic epidermal necrolysis due to lansoprazole.
Clinical and experimental dermatology 20060101
-
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
International journal of molecular medicine 20060101
-
Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
Clinical pharmacology and therapeutics 20060101
-
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Digestive diseases and sciences 20060101
-
Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060101
-
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101
-
Cholecystoduodenal fistula secondary to penetrating duodenal ulcer: a case of conservative management.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20060101
-
Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.
Xenobiotica; the fate of foreign compounds in biological systems 20060101
-
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20060101
-
Intravenous proton pump inhibitors.
Reviews in gastroenterological disorders 20060101
-
Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites.
Clinical hemorheology and microcirculation 20060101
-
Functional complementation of the yeast P-type H-ATPase, PMA1, by the Pneumocystis carinii P-type H-ATPase, PCA1.
The Journal of eukaryotic microbiology 20060101
-
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Journal of gastroenterology and hepatology 20060101
-
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
Journal of investigational allergology & clinical immunology 20060101
-
Effect of proton pump inhibitors on hepatic regeneration.
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101
-
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey.
Acta haematologica 20060101
-
Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers.
Clinical drug investigation 20060101
-
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20060101
-
Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms--a pilot study.
Advances in medical sciences 20060101
-
Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.
Alimentary pharmacology & therapeutics 20051201
-
Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Journal of gastroenterology and hepatology 20051201
-
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
The American journal of gastroenterology 20051201
-
[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
Nihon rinsho. Japanese journal of clinical medicine 20051201
-
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
Annals of hematology 20051101
-
Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children.
International journal of pediatric otorhinolaryngology 20051101
-
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
The Annals of pharmacotherapy 20051101
-
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101
-
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Journal of gastroenterology and hepatology 20051101
-
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
The American journal of medicine 20051101
-
'Proton-pump inhibitor-first' strategy versus 'step-up' strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
Journal of gastroenterology 20051101
-
Helicobacter pylori treatment.
Southern medical journal 20051101
-
Effect of N-acetyl cysteine on Helicobacter pylori.
Southern medical journal 20051101
-
[Guidelines in the management of H. pylori infection in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[H. pylori motility analysis].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Cap polyposis and Helicobacter pylori].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Recent topics on important drugs for H. pylori eradication: Lansoprazole].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[H. pylori eradication package set (Lansap)].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Triple therapy for eradication of Helicobacter pylori in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Adverse effects of Helicobacter pylori eradication and its prevention].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[PPI plus bismuth-based quintuple therapy].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Investigation about 3rd line eradication of H. pylori].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Helicobacter pylori eradication therapy for children].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Nihon rinsho. Japanese journal of clinical medicine 20051101
-
Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents.
Journal of ethnopharmacology 20051003
-
A decade-long sour-taste sensation successfully treated with a proton-pump inhibitor.
Journal of oral rehabilitation 20051001
-
Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
Journal of clinical pharmacology 20051001
-
Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
Alimentary pharmacology & therapeutics 20051001
-
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Gastroenterologia y hepatologia 20051001
-
Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
Current medical research and opinion 20051001
-
Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
European journal of pharmacology 20050920
-
Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050901
-
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Journal of gastroenterology and hepatology 20050901
-
Determinants of non-response in Helicobacter pylori eradication trials.
Journal of gastroenterology and hepatology 20050901
-
Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
Chest 20050901
-
Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
Clinical therapeutics 20050901
-
Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube.
International journal of pharmaceutics 20050811
-
Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors.
Allergy 20050801
-
[The clinical strategy for the Barrett's esophagus].
Nihon rinsho. Japanese journal of clinical medicine 20050801
-
A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Digestive diseases and sciences 20050801
-
[The cause of failure of eradication treatment of Helicobacter pylori].
Rinsho byori. The Japanese journal of clinical pathology 20050801
-
Mechanisms of action of leptin in preventing gastric ulcer.
World journal of gastroenterology 20050721
-
A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 20050715
-
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
World journal of gastroenterology 20050714
-
Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
American journal of physiology. Gastrointestinal and liver physiology 20050701
-
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701
-
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
Alimentary pharmacology & therapeutics 20050701
-
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
British journal of clinical pharmacology 20050701
-
Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701
-
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Pathology international 20050701
-
Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
The Laryngoscope 20050701
-
Lansoprazole-associated collagenous colitis: a case report.
Zeitschrift fur Gastroenterologie 20050701
-
Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
Digestive diseases and sciences 20050701
-
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
World journal of gastroenterology 20050614
-
Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes.
Chirality 20050601
-
Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes.
Journal of clinical pharmacology 20050601
-
CYP35: xenobiotically induced gene expression in the nematode Caenorhabditis elegans.
Archives of biochemistry and biophysics 20050601
-
Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Alimentary pharmacology & therapeutics 20050601
-
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050601
-
Prediction of genotoxicity of chemical compounds by statistical learning methods.
Chemical research in toxicology 20050601
-
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.
Drug metabolism and pharmacokinetics 20050601
-
The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Research in social & administrative pharmacy : RSAP 20050601
-
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
Alimentary pharmacology & therapeutics 20050515
-
Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?
Journal of the European Academy of Dermatology and Venereology : JEADV 20050501
-
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Digestive diseases and sciences 20050501
-
Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients.
Digestive diseases and sciences 20050501
-
Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of 'cluster GERD.'.
Digestive diseases and sciences 20050501
-
[Role of esophageal motility abnormalities in severe reflux esophagitis].
Zhonghua nei ke za zhi 20050501
-
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers.
Xenobiotica; the fate of foreign compounds in biological systems 20050501
-
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
World journal of gastroenterology 20050421
-
[Distribution of Helicobacter pylori in stomach before and after the administration of Lansoprazole].
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050418
-
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
Arthritis and rheumatism 20050415
-
[Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
MMW Fortschritte der Medizin 20050407
-
Antimicrobial actions of benzimidazoles against oral streptococci.
Oral microbiology and immunology 20050401
-
Hyponatremia with consciousness disturbance associated with esomeprazole.
The Annals of pharmacotherapy 20050401
-
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity.
Scandinavian journal of gastroenterology 20050401
-
Lack of interaction between atazanavir and lansoprazole.
AIDS (London, England) 20050324
-
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Alimentary pharmacology & therapeutics 20050315
-
[Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
MMW Fortschritte der Medizin 20050303
-
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques.
Journal of medical microbiology 20050301
-
Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
Journal of pediatric gastroenterology and nutrition 20050301
-
Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager.
Journal of pediatric gastroenterology and nutrition 20050301
-
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
Virchows Archiv : an international journal of pathology 20050301
-
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
British journal of clinical pharmacology 20050301
-
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.
Digestive diseases and sciences 20050301
-
Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.
Irish medical journal 20050301
-
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050301
-
Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225
-
The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells.
European journal of pharmacology 20050221
-
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
World journal of gastroenterology 20050221
-
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
World journal of gastroenterology 20050221
-
Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
Alimentary pharmacology & therapeutics 20050215
-
Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.
Drug metabolism and disposition: the biological fate of chemicals 20050201
-
Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test.
Medical science monitor : international medical journal of experimental and clinical research 20050201
-
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.
Alimentary pharmacology & therapeutics 20050201
-
Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
Helicobacter 20050201
-
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.
The Journal of pharmacy and pharmacology 20050201
-
Effect of adsorbents on the absorption of lansoprazole with surfactant.
International journal of pharmaceutics 20050131
-
Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.
Alimentary pharmacology & therapeutics 20050115
-
Neuropathy associated with lansoprazole treatment.
Muscle & nerve 20050101
-
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
The Annals of pharmacotherapy 20050101
-
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
The Annals of thoracic surgery 20050101
-
Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050101
-
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
European journal of gastroenterology & hepatology 20050101
-
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
Journal of gastroenterology 20050101
-
The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101
-
Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.
Xenobiotica; the fate of foreign compounds in biological systems 20050101
-
Why is this woman smiling? The hard sell of bad medicine.
Revolution (Oakland, Calif.) 20050101
-
Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders.
Drugs 20050101
-
[Pharmacogenomical aspects of gastroesophageal reflux disease].
Vestnik Rossiiskoi akademii meditsinskikh nauk 20050101
-
Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial.
Arquivos de gastroenterologia 20050101
-
Haemorrhagic gastritis and bleeding following rofecoxib administration.
Clinical and experimental rheumatology 20050101
-
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Acta dermato-venereologica 20050101
-
Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.
Drugs 20050101
-
Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis.
Inflammopharmacology 20050101
-
What is potent acid inhibition, and how can it be achieved?
Drugs 20050101
-
Gastroesophageal reflux disease and extraesophageal disease.
Reviews in gastroenterological disorders 20050101
-
Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules.
Clinical therapeutics 20041201
-
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201
-
Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes.
European journal of clinical pharmacology 20041101
-
Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.
Journal of clinical pharmacology 20041101
-
Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection.
Scandinavian journal of gastroenterology 20041101
-
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils.
Cancer science 20041101
-
Fatal toxic epidermal necrolysis due to lansoprazole.
Clinical and experimental dermatology 20041101
-
Patent expiration for lansoprazole.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101
-
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101
-
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Journal of gastroenterology 20041101
-
[Choice of proton pump inhibitors--does it play any role?].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021
-
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis.
Alimentary pharmacology & therapeutics 20041015
-
[Galactorrhea induced by lansoprazole].
Atencion primaria 20041015
-
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
World journal of gastroenterology 20041001
-
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
European journal of clinical pharmacology 20041001
-
On-demand PPI requirements in patients with endoscopy-negative GERD.
Journal of clinical gastroenterology 20041001
-
The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
Journal of clinical gastroenterology 20041001
-
Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.
European journal of gastroenterology & hepatology 20041001
-
Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment.
Clinical and laboratory haematology 20041001
-
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041001
-
Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects.
Drug metabolism and pharmacokinetics 20041001
-
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Journal of gastroenterology 20041001
-
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Clinical therapeutics 20041001
-
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
Archives of internal medicine 20040927
-
Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection.
Journal of pharmaceutical and biomedical analysis 20040921
-
Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.
Alimentary pharmacology & therapeutics 20040915
-
Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
The American journal of medicine 20040906
-
Management of acid-related disorders in patients with dysphagia.
The American journal of medicine 20040906
-
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.
Clinical pharmacology and therapeutics 20040901
-
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
The Laryngoscope 20040901
-
Serum cholinesterase inhibition by omeprazole and lansoprazole.
Die Pharmazie 20040901
-
Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.
Scandinavian journal of gastroenterology 20040901
-
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
Journal of gastroenterology 20040901
-
A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube.
Alimentary pharmacology & therapeutics 20040815
-
Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
International immunopharmacology 20040801
-
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Drug metabolism and disposition: the biological fate of chemicals 20040801
-
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Helicobacter 20040801
-
Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial.
Alimentary pharmacology & therapeutics 20040801
-
Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.
The Journal of pharmacy and pharmacology 20040801
-
Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes.
Acta pharmacologica Sinica 20040801
-
Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
The American journal of gastroenterology 20040801
-
[Primary care for GEDR].
Nihon rinsho. Japanese journal of clinical medicine 20040801
-
[Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
Nihon rinsho. Japanese journal of clinical medicine 20040801
-
[PPI: new strategies for GERD].
Nihon rinsho. Japanese journal of clinical medicine 20040801
-
Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography.
Journal of separation science 20040801
-
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
Wiener klinische Wochenschrift 20040731
-
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Deutsche medizinische Wochenschrift (1946) 20040709
-
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040701
-
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
Alimentary pharmacology & therapeutics 20040701
-
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Alimentary pharmacology & therapeutics 20040701
-
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Alimentary pharmacology & therapeutics 20040701
-
Wyeth found guilty of paying to boost use of a specific medicine.
BMJ (Clinical research ed.) 20040626
-
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20040615
-
Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601
-
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
The American journal of medicine 20040601
-
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Journal of gastroenterology and hepatology 20040601
-
A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.
Alimentary pharmacology & therapeutics 20040601
-
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
World journal of gastroenterology 20040601
-
Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient.
Clinical and experimental nephrology 20040601
-
The influence of pretreatment on cure rates of Helicobacter pylori eradication.
The Netherlands journal of medicine 20040601
-
Evaluation of fast disintegrating lansoprazole tablet in human subjects.
Drug metabolism and pharmacokinetics 20040601
-
Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525
-
Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole.
Alimentary pharmacology & therapeutics 20040515
-
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Alimentary pharmacology & therapeutics 20040515
-
Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.
The Annals of pharmacotherapy 20040501
-
Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers.
Journal of gastroenterology and hepatology 20040501
-
Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy.
Archives of surgery (Chicago, Ill. : 1960) 20040501
-
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20040501
-
Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate.
Xenobiotica; the fate of foreign compounds in biological systems 20040501
-
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Langenbeck's archives of surgery 20040401
-
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Helicobacter 20040401
-
Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.
The American journal of gastroenterology 20040401
-
Helicobacter pylori eradication: efficacy of conventional therapy in India.
Tropical doctor 20040401
-
Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
Biological & pharmaceutical bulletin 20040301
-
[Myoclonic encephalopathy associated with proton pump inhibitors].
Revue neurologique 20040301
-
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Nihon rinsho. Japanese journal of clinical medicine 20040301
-
[Effect of proton pump inhibitors (PPIs) on wound healing of gastric mucosal cell injury].
Nihon rinsho. Japanese journal of clinical medicine 20040301
-
Schatzki's ring: to cut or break an unresolved problem.
Digestive diseases and sciences 20040301
-
The acidity index: a simple approach to the measurement of gastric acidity.
Alimentary pharmacology & therapeutics 20040215
-
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 20040215
-
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Toxicology and applied pharmacology 20040215
-
Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201
-
Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
Journal of pediatric surgery 20040201
-
Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20040101
-
Managing gastro-oesophageal reflux disease in children.
Digestion 20040101
-
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101
-
Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years.
Paediatric drugs 20040101
-
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20040101
-
Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Hepato-gastroenterology 20040101
-
[Cross reactivity among proton pump inhibitors: does it exits?].
Allergologia et immunopathologia 20040101
-
An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole.
Hepato-gastroenterology 20040101
-
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.
Arzneimittel-Forschung 20040101
-
[Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
Annali italiani di chirurgia 20040101
-
[Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
Mikrobiyoloji bulteni 20040101
-
Delayed-release lansoprazole plus naproxen.
Drugs 20040101
-
Intravenous lansoprazole: in erosive oesophagitis.
Drugs 20040101
-
Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Hepato-gastroenterology 20040101
-
Effectiveness of proton pump inhibitors: beyond cost.
Reviews in gastroenterological disorders 20040101
-
Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?
Digestive diseases and sciences 20040101
-
[Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].
Revista de gastroenterologia de Mexico 20040101
-
In vivo and in vitro research on the biological effects of deuterium-depleted water: 1. Influence of deuterium-depleted water on cultured cell growth.
Romanian journal of physiology : physiological sciences 20040101
-
A 100 kDa vanadate and lanzoprazole-sensitive ATPase from Streptococcus mutans membrane.
Archives of oral biology 20031201
-
Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031201
-
Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.
Alimentary pharmacology & therapeutics 20031201
-
Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.
Alimentary pharmacology & therapeutics 20031201
-
Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
Journal of gastroenterology and hepatology 20031201
-
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
The American journal of gastroenterology 20031201
-
Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?
Scandinavian journal of gastroenterology 20031201
-
In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Hepato-gastroenterology 20031201
-
Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole.
Histochemistry and cell biology 20031101
-
Lansoprazole-induced hepatic dysfunction.
The Annals of pharmacotherapy 20031101
-
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
The American journal of gastroenterology 20031101
-
[The treatment of Helicobacter pylori infection in upper gastrointestinal disorders].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20031101
-
['Mirror, mirror on the wall which is the best proton pump inhibitor of all?'].
Zeitschrift fur Gastroenterologie 20031101
-
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
Alimentary pharmacology & therapeutics 20031015
-
Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis.
Toxicology and applied pharmacology 20031015
-
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Journal of medicinal chemistry 20031009
-
Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.
Drug metabolism and disposition: the biological fate of chemicals 20031001
-
Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.
Chemical & pharmaceutical bulletin 20031001
-
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
-
Proton pump inhibitors in children: a review.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
-
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Archives of internal medicine 20030922
-
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.
Alimentary pharmacology & therapeutics 20030915
-
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20030915
-
Formulation study for lansoprazole fast-disintegrating tablet. II. Effect of triethyl citrate on the quality of the products.
Chemical & pharmaceutical bulletin 20030901
-
Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
The American journal of gastroenterology 20030901
-
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
The American journal of gastroenterology 20030901
-
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
The Keio journal of medicine 20030901
-
The impact of gastroesophageal reflux disease on quality of life.
Surgical endoscopy 20030801
-
Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior.
Chemical & pharmaceutical bulletin 20030801
-
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
World journal of gastroenterology 20030715
-
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
Alimentary pharmacology & therapeutics 20030701
-
Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701
-
[Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20030701
-
A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
Clinical therapeutics 20030701
-
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030701
-
[All proton pump inhibitors are equally efficacious in standard dosages].
Lakartidningen 20030619
-
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
Alimentary pharmacology & therapeutics 20030615
-
How can the current strategies for Helicobacter pylori eradication therapy be improved?
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030601
-
[In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20030601
-
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20030515
-
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Alimentary pharmacology & therapeutics 20030515
-
Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice.
European journal of pharmacology 20030502
-
Diarrhea associated with lansoprazole.
Journal of gastroenterology and hepatology 20030501
-
Lansoprazole overutilization: methods for step-down therapy.
The American journal of managed care 20030501
-
The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
The Journal of laryngology and otology 20030501
-
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
European journal of pharmacology 20030411
-
The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism.
Alimentary pharmacology & therapeutics 20030401
-
Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review.
Helicobacter 20030401
-
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Helicobacter 20030401
-
Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode.
Journal of pharmaceutical and biomedical analysis 20030401
-
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
Alimentary pharmacology & therapeutics 20030401
-
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin.
Epidemiology and infection 20030401
-
Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers.
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20030401
-
A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.
The Journal of biological chemistry 20030328
-
Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.
Alimentary pharmacology & therapeutics 20030315
-
Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors.
Biological & pharmaceutical bulletin 20030301
-
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
British journal of haematology 20030301
-
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Chest 20030301
-
The prophylactic use of a proton pump inhibitor before food and alcohol.
Alimentary pharmacology & therapeutics 20030301
-
Does eradication of Helicobacter pylori reduce hypergastrinaemia during long term therapy with proton pump inhibitors?
East African medical journal 20030301
-
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
Journal of gastroenterology and hepatology 20030201
-
An aspirin a day keeps the cardiologist away (but what about the gastroenterologist?).
Gastroenterology 20030201
-
Reflux disease and Barrett's esophagus.
Endoscopy 20030201
-
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Alimentary pharmacology & therapeutics 20030201
-
Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects.
Alimentary pharmacology & therapeutics 20030201
-
Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.
Alimentary pharmacology & therapeutics 20030201
-
Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis.
Alimentary pharmacology & therapeutics 20030201
-
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Alimentary pharmacology & therapeutics 20030201
-
Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
Xenobiotica; the fate of foreign compounds in biological systems 20030201
-
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
The journal of medical investigation : JMI 20030201
-
[Guidelines in the management of Helicobacter pylori infection in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20030201
-
Lansoprazole quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030115
-
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.
Alimentary pharmacology & therapeutics 20030101
-
Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity.
Reproductive toxicology (Elmsford, N.Y.) 20030101
-
Lansoprazole: in the management of gastroesophageal reflux disease in children.
Paediatric drugs 20030101
-
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.
Alimentary pharmacology & therapeutics 20030101
-
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
Alimentary pharmacology & therapeutics 20030101
-
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
European journal of gastroenterology & hepatology 20030101
-
[New triple therapy for Helicobacter pylori infection in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20030101
-
Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool.
Journal of gastroenterology 20030101
-
Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
Digestion 20030101
-
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Journal of gastroenterology 20030101
-
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
Journal of gastroenterology 20030101
-
Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Hepato-gastroenterology 20030101
-
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20030101
-
Compartment theory in Helicobacter pylori-associated gastric carcinogenesis.
Anticancer research 20030101
-
Quality of life and cost-effectiveness of combined therapy for reflux esophagitis.
Journal of Zhejiang University. Science 20030101
-
Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450.
American journal of therapeutics 20030101
-
Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro.
Journal of gastroenterology 20030101
-
Improving health-related quality of life in gastro-oesophageal reflux disease.
Drugs 20030101
-
[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
Klinicheskaia meditsina 20030101
-
An overview of proton pump inhibitors.
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101
-
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
Journal of gastroenterology 20030101
-
Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Journal of gastroenterology 20030101
-
Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics.
Journal of pediatric gastroenterology and nutrition 20030101
-
Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers.
Digestion 20030101
-
Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
The Journal of pharmacology and experimental therapeutics 20021201
-
The pharmacology and clinical relevance of proton pump inhibitors.
Current gastroenterology reports 20021201
-
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
Helicobacter 20021201
-
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
ANZ journal of surgery 20021201
-
Facial swelling and eosinophilia in a 44-year-old woman.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201
-
Low-dose aspirin: protection from the panacea.
The American journal of gastroenterology 20021201
-
Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute?
Pharmacoepidemiology and drug safety 20021201
-
Transport through liquid membranes containing omeprazole and lansoprazole.
Indian journal of biochemistry & biophysics 20021201
-
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
The New England journal of medicine 20021114
-
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
Journal of pharmaceutical and biomedical analysis 20021107
-
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Alimentary pharmacology & therapeutics 20021101
-
Restoration of acid secretion following treatment with proton pump inhibitors.
Gastroenterology 20021101
-
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
The Journal of antimicrobial chemotherapy 20021101
-
Lansoprazole-associated microscopic colitis: a case series.
The American journal of gastroenterology 20021101
-
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.
Transplantation proceedings 20021101
-
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20021101
-
Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.
International journal of urology : official journal of the Japanese Urological Association 20021101
-
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
Archives of internal medicine 20021028
-
[In small steps to far ahead. Diminished risk of interactions as definite advantage].
MMW Fortschritte der Medizin 20021010
-
Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning.
Cell 20021004
-
Functional dyspepsia: bye-bye to PPIs.
Gut 20021001
-
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
Gut 20021001
-
Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.
Alimentary pharmacology & therapeutics 20021001
-
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
The American journal of gastroenterology 20021001
-
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole.
Clinical pharmacology and therapeutics 20021001
-
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Helicobacter 20021001
-
Medication errors. Liquid lansoprazole: gumming up the works.
Nursing 20021001
-
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20020901
-
Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.
Diseases of the colon and rectum 20020901
-
Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
The American journal of gastroenterology 20020901
-
Motion--Helicobacter pylori worsens GERD: arguments for the motion.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901
-
Motion--Helicobacter pylori causes or worsens GERD: arguments against the motion.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901
-
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.
British journal of cancer 20020827
-
Tetany secondary to the use of a proton-pump inhibitor.
Annals of internal medicine 20020806
-
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.
British journal of haematology 20020801
-
Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin.
The Journal of antimicrobial chemotherapy 20020801
-
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Helicobacter 20020801
-
One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease.
European journal of gastroenterology & hepatology 20020801
-
[Reflux esophagitis].
Nihon rinsho. Japanese journal of clinical medicine 20020801
-
[Eradication therapy of Helicobacter pylori for elderly patients in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20020801
-
[Several points that should be noticed during PPI treatment for peptic ulcers in elderly patients].
Nihon rinsho. Japanese journal of clinical medicine 20020801
-
Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation.
Clinical therapeutics 20020801
-
Proton pump inhibitors: an update.
American family physician 20020715
-
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Journal of gastroenterology and hepatology 20020701
-
[Eradication of helicobacter pylori: symptomatic treatment of reflux disease?].
Zeitschrift fur Gastroenterologie 20020701
-
An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
Alimentary pharmacology & therapeutics 20020701
-
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Clinical pharmacology and therapeutics 20020701
-
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.
Clinical pharmacology and therapeutics 20020701
-
[Treatment of NSAID-associated gastric ulcer].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020701
-
Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
Managed care (Langhorne, Pa.) 20020701
-
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
The New England journal of medicine 20020627
-
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.
Alimentary pharmacology & therapeutics 20020601
-
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Alimentary pharmacology & therapeutics 20020601
-
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Helicobacter 20020601
-
Symptomatic ulceration of an acid-producing oesophageal inlet patch colonized by helicobacter pylori.
Endoscopy 20020601
-
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
European journal of gastroenterology & hepatology 20020601
-
Protection against aspiration with the Proseal laryngeal mask airway.
Anaesthesia and intensive care 20020601
-
Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
The American journal of gastroenterology 20020601
-
Osteoporosis with underlying connective tissue disease: an unusual case.
Annals of the New York Academy of Sciences 20020601
-
On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole.
Scandinavian journal of gastroenterology 20020601
-
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Internal medicine (Tokyo, Japan) 20020601
-
Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.
Alimentary pharmacology & therapeutics 20020501
-
Lansoprazole-induced thrombocytopenia.
The Annals of pharmacotherapy 20020501
-
Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
Clinical pharmacology and therapeutics 20020501
-
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
The Journal of biological chemistry 20020419
-
Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report.
Gastrointestinal endoscopy 20020401
-
Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
Alimentary pharmacology & therapeutics 20020401
-
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Helicobacter 20020401
-
Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis?
Obesity surgery 20020401
-
Effect of hypergastrinemia on pancreatic carcinogenesis.
American journal of surgery 20020401
-
Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis?
The Journal of family practice 20020401
-
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.
The Journal of pharmacy and pharmacology 20020401
-
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Gastroenterologie clinique et biologique 20020401
-
[Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020320
-
Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20020301
-
Acid suppression in healthy subjects following lansoprazole or pantoprazole.
Alimentary pharmacology & therapeutics 20020301
-
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Alimentary pharmacology & therapeutics 20020301
-
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 20020301
-
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.
Alimentary pharmacology & therapeutics 20020301
-
A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
Clinical and experimental pharmacology & physiology 20020301
-
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
The American journal of gastroenterology 20020301
-
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy.
The American journal of gastroenterology 20020301
-
An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
International journal of clinical practice 20020301
-
Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Gastroenterologie clinique et biologique 20020301
-
Collagenous colitis associated with lansoprazole.
Journal of clinical gastroenterology 20020201
-
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Alimentary pharmacology & therapeutics 20020201
-
Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.
Alimentary pharmacology & therapeutics 20020201
-
In support of 'step-up therapy' for gastroesophageal reflux disease.
The American journal of gastroenterology 20020201
-
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020201
-
Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201
-
Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201
-
[The outline of medical treatment of peptic ulcer].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Guidelines for the management of Helicobacter pylori infection in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[New triple therapy for Helicobacter pylori infection].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Adverse effects of H. pylori eradication therapy and its measure].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[H. pylori eradication therapy and natural history of peptic ulcer].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Treatment of NSAIDs induced ulcers].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Intractable ulcer].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Gastroduodenal ulcer in childhood].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Peptic ulcer in the elderly].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Plaunotol].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Ecabet sodium].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Polaprezinc].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Cause and prevention of nocturnal gastric acid breakthrough].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Helicobacter heilmannii-associated gastritis].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
Conformational analysis: a new approach by means of chemometrics.
Journal of computational chemistry 20020130
-
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Archives of internal medicine 20020128
-
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Archives of internal medicine 20020128
-
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.
Transplantation 20020127
-
Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
The New England journal of medicine 20020110
-
[Progress of tailor-made treatment of peptic ulcer].
Nihon rinsho. Japanese journal of clinical medicine 20020101
-
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
International journal of antimicrobial agents 20020101
-
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.
The Journal of dermatology 20020101
-
Acute manic psychosis induced by triple therapy for H. pylori.
The Journal of the American Board of Family Practice 20020101
-
Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.
Alimentary pharmacology & therapeutics 20020101
-
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 20020101
-
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Alimentary pharmacology & therapeutics 20020101
-
Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101
-
Dual versus triple therapy in eradication of Helicobacter pylori.
Hepato-gastroenterology 20020101
-
One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy.
Journal of clinical gastroenterology 20020101
-
Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study.
Drug safety 20020101
-
Lansoprazole for maintenance of remission of erosive oesophagitis.
Drugs 20020101
-
Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study.
American journal of therapeutics 20020101
-
Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.
BMC gastroenterology 20020101
-
Gastroesophageal reflux disease: new treatments.
Reviews in gastroenterological disorders 20020101
-
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].
Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20020101
-
[Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori].
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20020101
-
Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers.
The Journal of international medical research 20020101
-
Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.
Paediatric drugs 20020101
-
[Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
-
[Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
Klinicheskaia meditsina 20020101
-
Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
Therapie 20020101
-
[Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer].
Likars'ka sprava 20020101
-
Anaphylaxis to proton pump inhibitors.
Allergologia et immunopathologia 20020101
-
ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells.
Anticancer research 20020101
-
Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
Journal of pediatric gastroenterology and nutrition 20020101
-
Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.
Journal of pediatric gastroenterology and nutrition 20020101
-
Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.
Journal of pediatric gastroenterology and nutrition 20020101
-
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Journal of pediatric gastroenterology and nutrition 20020101
-
Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin.
The Journal of antimicrobial chemotherapy 20011201
-
Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
European journal of gastroenterology & hepatology 20011201
-
Gastroesophageal reflux in infants and children.
American family physician 20011201
-
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
Naunyn-Schmiedeberg's archives of pharmacology 20011201
-
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20011201
-
Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.
European journal of clinical pharmacology 20011201
-
A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible.
Archives of biochemistry and biophysics 20011115
-
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Alimentary pharmacology & therapeutics 20011101
-
Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
Alimentary pharmacology & therapeutics 20011101
-
A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.
Alimentary pharmacology & therapeutics 20011101
-
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
Alimentary pharmacology & therapeutics 20011101
-
Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication.
European journal of gastroenterology & hepatology 20011101
-
Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.
Digestive diseases and sciences 20011101
-
Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.
Clinical pharmacology and therapeutics 20011101
-
Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
The American journal of gastroenterology 20011101
-
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm.
Diagnostic cytopathology 20011101
-
Pill-induced esophagitis caused by lansoprazole.
Journal of gastroenterology 20011101
-
Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).
The Laryngoscope 20011101
-
[Lansoprazole-associated collagenous colitis].
Gastroenterologie clinique et biologique 20011101
-
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
Journal of gastroenterology and hepatology 20011101
-
Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20011001
-
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001
-
What is the best pharmacologic approach to managing moderate to severe heartburn?
The Journal of family practice 20011001
-
Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy.
Digestive diseases and sciences 20011001
-
A bioavailability/bioequivalence study of two oral lansoprazole formulations after single administration to healthy volunteers.
Die Pharmazie 20011001
-
[Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials].
Nihon Jibiinkoka Gakkai kaiho 20011001
-
Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
Expert opinion on pharmacotherapy 20011001
-
Noninvasive Helicobacter pylori testing for the 'test-and-treat' strategy: a decision analysis to assess the effect of past infection on test choice.
Archives of internal medicine 20010924
-
Clinical and ethical concerns about switching patient treatment to 'therapeutically interchangeable' medications.
Archives of internal medicine 20010924
-
[Comparative study of proton pump inhibitors].
Orvosi hetilap 20010909
-
Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
Journal of clinical gastroenterology 20010901
-
Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
Gut 20010901
-
Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis.
Alimentary pharmacology & therapeutics 20010901
-
Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?
Alimentary pharmacology & therapeutics 20010901
-
Review article: tackling the 'dyspeptic problem'.
Alimentary pharmacology & therapeutics 20010901
-
Review article: managing the dyspeptic patient--an interactive discussion.
Alimentary pharmacology & therapeutics 20010901
-
Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.
Journal of pediatric gastroenterology and nutrition 20010901
-
Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?
Journal of pediatric gastroenterology and nutrition 20010901
-
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Helicobacter 20010901
-
Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism.
European journal of clinical pharmacology 20010901
-
[Complementary observational study of the efficacy, tolerance and safety of lansoprazole 15 mg as maintenance therapy of reflux esophagitis in daily medical practice in Belgium (record RU49749/R002].
Revue medicale de Liege 20010901
-
Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010815
-
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Alimentary pharmacology & therapeutics 20010801
-
High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
Scandinavian journal of gastroenterology 20010801
-
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
The American journal of gastroenterology 20010801
-
[Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010801
-
Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion.
European journal of gastroenterology & hepatology 20010801
-
Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
European journal of gastroenterology & hepatology 20010801
-
Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010715
-
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Alimentary pharmacology & therapeutics 20010701
-
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
Postgraduate medical journal 20010701
-
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
Gastrointestinal endoscopy 20010701
-
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
The American journal of gastroenterology 20010701
-
Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms.
Digestive diseases and sciences 20010701
-
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Hospital medicine (London, England : 1998) 20010701
-
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Clinical therapeutics 20010701
-
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore.
Singapore medical journal 20010701
-
High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.
Journal of chromatography. B, Biomedical sciences and applications 20010605
-
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
Lancet (London, England) 20010602
-
Proton pump inhibitors: a study of GPs' prescribing.
Family practice 20010601
-
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
Microscopy research and technique 20010601
-
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.
Alimentary pharmacology & therapeutics 20010601
-
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
The Laryngoscope 20010601
-
Treatment of gastroesophageal reflux disease: to step or not to step.
The American journal of gastroenterology 20010601
-
Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
The American journal of gastroenterology 20010601
-
Discoloured tongue: a new cause?
The British journal of dermatology 20010601
-
Helicobacter pylori and early duodenal ulcer status post-treatment: a review.
Helicobacter 20010601
-
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Journal of gastroenterology and hepatology 20010601
-
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given?
Scandinavian journal of gastroenterology 20010601
-
Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
Medical mycology 20010601
-
Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy.
Pharmacy world & science : PWS 20010601
-
CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.
Pharmaceutical research 20010601
-
Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.
Alimentary pharmacology & therapeutics 20010501
-
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.
Digestive diseases and sciences 20010501
-
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Inflammatory bowel diseases 20010501
-
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Clinical therapeutics 20010501
-
Proton pump inhibitors and their drug interactions: an evidence-based approach.
European journal of gastroenterology & hepatology 20010501
-
Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections.
Journal of pediatric gastroenterology and nutrition 20010501
-
Shortcomings of the first-generation proton pump inhibitors.
European journal of gastroenterology & hepatology 20010501
-
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
La Revue du praticien 20010415
-
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue.
The Journal of antimicrobial chemotherapy 20010401
-
Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
Alimentary pharmacology & therapeutics 20010401
-
Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor.
The American journal of gastroenterology 20010401
-
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
The American journal of gastroenterology 20010401
-
Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401
-
[Gynecomastia associated with the simultaneous use of cisapride and lansoprazole].
Medicina clinica 20010324
-
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Life sciences 20010309
-
Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Annals of internal medicine 20010306
-
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Gut 20010301
-
Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast and Lanzor) in healthy volunteers.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20010301
-
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Gastrointestinal endoscopy 20010301
-
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Clinical pharmacology and therapeutics 20010301
-
Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs.
Biological & pharmaceutical bulletin 20010301
-
Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
Journal of clinical pharmacology 20010301
-
Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals.
The Analyst 20010301
-
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
The Israel Medical Association journal : IMAJ 20010301
-
Gastroprotective effect of aparisthman, a diterpene isolated from Aparisthmium cordatum, on experimental gastric ulcer models in rats and mice.
Phytomedicine : international journal of phytotherapy and phytopharmacology 20010301
-
Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
Gastroenterologie clinique et biologique 20010301
-
Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection.
FEBS letters 20010202
-
Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
Alimentary pharmacology & therapeutics 20010201
-
Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis.
Alimentary pharmacology & therapeutics 20010201
-
[Recent guidelines for the management of Helicobacter pylori infection].
Nihon rinsho. Japanese journal of clinical medicine 20010201
-
[Usefulness of new triple therapy containing PPI].
Nihon rinsho. Japanese journal of clinical medicine 20010201
-
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].
Nihon rinsho. Japanese journal of clinical medicine 20010201
-
Aggressive acid control: minimizing progression of Barrett's esophagus.
The American journal of managed care 20010201
-
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
Journal of gastroenterology 20010201
-
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
The American journal of gastroenterology 20010201
-
[Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010201
-
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
The American journal of medicine 20010108
-
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Alimentary pharmacology & therapeutics 20010101
-
Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.
Alimentary pharmacology & therapeutics 20010101
-
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.
Journal of clinical gastroenterology 20010101
-
Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor.
Contact dermatitis 20010101
-
Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.
Pediatric pulmonology 20010101
-
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
Revista do Hospital das Clinicas 20010101
-
Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers.
Digestion 20010101
-
[The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis].
Klinicheskaia meditsina 20010101
-
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Digestive diseases (Basel, Switzerland) 20010101
-
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy.
Digestive diseases (Basel, Switzerland) 20010101
-
Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time.
Digestion 20010101
-
The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
Managed care interface 20010101
-
Gastroesophageal reflux disease presenting as xerophthalmia.
Journal of pediatric ophthalmology and strabismus 20010101
-
Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101
-
Lansoprazole: an update of its place in the management of acid-related disorders.
Drugs 20010101
-
Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.
Scandinavian journal of gastroenterology. Supplement 20010101
-
A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Effective clinical practice : ECP 20010101
-
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Acta medica (Hradec Kralove) 20010101
-
Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20001101
-
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
British journal of clinical pharmacology 20001001
-
Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.
Drug metabolism and disposition: the biological fate of chemicals 20000701
-
How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
European journal of gastroenterology & hepatology 20000601
-
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
The American journal of gastroenterology 20000201
-
[Mental confusion from interaction of a proton-pump inhibitor with benzodiazepines: 3 cases].
Therapie 20000101
-
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Journal of gastroenterology 20000101
-
Fluorometric screening for metabolism-based drug--drug interactions.
Journal of pharmacological and toxicological methods 20000101
-
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
Alimentary pharmacology & therapeutics 19991201
-
Rational prescribing: practice audit and drug switch in dyspepsia management.
International journal of clinical practice 19991201
-
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists.
Alimentary pharmacology & therapeutics 19990701
-
Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach.
Life sciences 19990101
-
Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification.
Chemical research in toxicology 19981201
-
Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans.
Digestive diseases and sciences 19981201
-
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Pharmacological research 19981201
-
Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long-term comparative study.
Alimentary pharmacology & therapeutics 19981001
-
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.
Chemico-biological interactions 19980703
-
Effects of a proton-pump inhibitor in cystic fibrosis.
Acta paediatrica (Oslo, Norway : 1992) 19980501
-
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Alimentary pharmacology & therapeutics 19980301
-
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 19980301
-
Possible lansoprazole-induced eosinophilic syndrome.
The Annals of pharmacotherapy 19980201
-
Famotidine-associated mental status changes.
Pharmacotherapy 19980101
-
The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R.
The Yale journal of biology and medicine 19980101
-
A prospective follow-up study of 5669 users of lansoprazole in daily practice.
Alimentary pharmacology & therapeutics 19971001
-
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
The American journal of gastroenterology 19970901
-
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
Drug metabolism and disposition: the biological fate of chemicals 19970501
-
[Lansoprazole-induced hepatitis].
Medicina clinica 19970419
-
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
The American journal of gastroenterology 19970301
-
Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
Alimentary pharmacology & therapeutics 19970201
-
Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.
Xenobiotica; the fate of foreign compounds in biological systems 19970101
-
Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects.
European journal of clinical pharmacology 19970101
-
Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis.
Clinical therapeutics 19970101
-
[A case of hemolysis induced by lansoprazole].
[Rinsho ketsueki] The Japanese journal of clinical hematology 19961201
-
[Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201
-
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201
-
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Helicobacter 19961201
-
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Helicobacter 19961201
-
[Internal medicine therapy in reflux disease].
Praxis 19961105
-
Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction.
Archives of biochemistry and biophysics 19961015
-
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
European journal of gastroenterology & hepatology 19961001
-
Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
The American journal of gastroenterology 19960901
-
A trial of lansoprazole in refractory gastric ulcer.
Alimentary pharmacology & therapeutics 19960601
-
Identification of the human P450 enzymes involved in lansoprazole metabolism.
The Journal of pharmacology and experimental therapeutics 19960501
-
Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism.
European journal of biochemistry 19960501
-
Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.
Fundamental and applied toxicology : official journal of the Society of Toxicology 19950701
-
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
European journal of gastroenterology & hepatology 19950701
-
[Drugs affecting gastric acidity in the therapy of ulcer disease].
Vnitrni lekarstvi 19950301
-
Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor.
Digestive diseases and sciences 19950301
-
Oxidative metabolism of lansoprazole by human liver cytochromes P450.
Molecular pharmacology 19950201
-
Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Digestion 19950101
-
Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa.
Journal of clinical gastroenterology 19950101
-
Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
The Journal of pharmacology and experimental therapeutics 19940401
-
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
The American journal of gastroenterology 19930801
-
[Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
Nihon rinsho. Japanese journal of clinical medicine 19920101
-
[Evaluation of the effect of proton pump inhibitors on stomal ulcer].
Nihon rinsho. Japanese journal of clinical medicine 19920101
-
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Japanese journal of pharmacology 19910401
-
H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.
Journal of clinical gastroenterology 19910101